NET PROFIT (x1000 EUR)
EMPLOYEES
Empros Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-1,013
|
-931
|
-825 |
| EBITDA |
-1,054
|
-1,053
|
-828 |
| Total assets |
11,281
|
13,272
|
6,889 |
| Current assets |
693
|
3,027
|
709 |
| Current liabilities |
94
|
643
|
429 |
| Equity capital |
11,187
|
12,629
|
6,460 |
| - share capital |
23
|
16
|
14 |
| Employees (average) |
8
|
8
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
99.2%
|
95.2%
|
93.8% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-9.0%
|
-7.0%
|
-12.0% |
| Current ratio |
737.2%
|
470.8%
|
165.3% |
| Return on equity (ROE) |
-9.1%
|
-7.4%
|
-12.8% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % |
0%
|
14%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.